Home › Funds › OSTERWEIS CAPITAL MANAGEMENT INC › RGEN

OSTERWEIS CAPITAL MANAGEMENT INC position in RGEN

REPLIGEN CORP · Health Care

OSTERWEIS CAPITAL MANAGEMENT INC reported holding 88,075 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$16.9M, representing 0.91% of its reported portfolio and ranking #36 among its reported holdings. OSTERWEIS CAPITAL MANAGEMENT INC has disclosed RGEN holdings in 9 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)88.08K sh
Reported value held$16.93M
Portfolio Weight0.91%
First reportedQ2 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How OSTERWEIS CAPITAL MANAGEMENT INC's RGEN position evolved

OSTERWEIS CAPITAL MANAGEMENT INC first disclosed a stake in RGEN in Q2 2024 at 36,035 shares (US$4.5M). The position peaked in Q3 2026 at 88,075 shares, worth US$16.9M. Across 9 filings, OSTERWEIS CAPITAL MANAGEMENT INC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 88,075 shares valued at US$16.9M — a reduction of -22,920 shares quarter over quarter.. Notable position changes include a 48% increase in Q3 2024 (shares fell 3% over the following quarter), a 25% trim in Q4 2025 (shares fell 28% over the following quarter), a 69% increase in Q1 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 36.03K $4.54M New
Q3 2024 53.45K $7.95M Add
Q4 2024 61.69K $8.88M Add
Q1 2025 72.77K $9.26M Add
Q3 2025 72.93K $9.75M New
Q4 2025 54.63K $8.95M Reduce
Q1 2026 92.22K $10.87M Add
Q2 2026 111.00K $15.14M Add
Q3 2026 88.08K $16.93M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has OSTERWEIS CAPITAL MANAGEMENT INC held RGEN?

OSTERWEIS CAPITAL MANAGEMENT INC has disclosed RGEN holdings in 9 of the last 10 reported quarters, going back to Q2 2024.

What is OSTERWEIS CAPITAL MANAGEMENT INC's current position in RGEN?

As of Q3 2026, OSTERWEIS CAPITAL MANAGEMENT INC holds 88.08K shares of RGEN (REPLIGEN CORP), valued at $16.93M, representing 0.91% of its reported portfolio and ranking #36.

Has OSTERWEIS CAPITAL MANAGEMENT INC been buying or selling RGEN?

In the latest 13F filing (Q3 2026), OSTERWEIS CAPITAL MANAGEMENT INC reduced its position in RGEN. The position peaked in Q3 2026 at 88.08K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.